Biotricity Inc. BTCY
0.07
0.00
0.00%
as of 25 Sep
- Market cap
- $10.9M
- P/E
- 0.0×
Follow BTCY
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
15.07% | 14.19% | 9.38% | 9.75% | |
| (83.81%) | (80.47%) | (51.76%) | (57.12%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
26.93% | 24.97% | 10.00% | 10.85% | |
Average Days of Receivables |
50.80 | 37.29 | 66.91 | 53.36 | |
Free Cash Flow per Share |
(0.02) | (0.04) | (0.03) | 0.01 | |
Free Cash Flow |
(0.45) | (1.10) | (0.72) | 0.16 | |
Piotroski F-Score |
6.00 | 4.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
6.02% | 14.78% | 9.15% | (1.96%) | |
Accounts Receivable Turnover |
8.38 | 10.98 | 6.97 | 7.70 | |
Accounts Payable Turnover |
0.36 | 0.35 | 0.37 | 0.35 | |
Inventory Turnover |
1.49 | 1.65 | 2.11 | 1.89 | |
Average Days of Payables |
949.19 | 1,065.81 | 1,073.78 | 1,117.44 | |
Days of Inventory on Hand |
270.82 | 246.66 | 160.55 | 171.19 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.06% | 16.15% | 17.28% | 16.72% | |
Selling, General and Administrative Expense of Revenue |
66.88% | 64.02% | 53.09% | 55.20% | |
Share Based Compensation of Revenue |
10.59% | 10.09% | 0.18% | 2.22% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.09 | 0.23 | 0.23 | (0.05) | |
Depreciation/Fixed assets |
123.77 | 147.59 | 208.83 | 368.32 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.56 | 0.56 | 0.59 | 0.71 | |
Operating CF per Share |
(0.02) | (0.04) | (0.03) | 0.01 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(32.27%) | (30.40%) | (19.56%) | (21.00%) |
Columns are period end dates